Breye Therapeutics
Denmark-based clinical-stage biopharmaceutical company
Breye Therapeutics has raised €72M across 2 funding rounds from 9 investors, most recently a Series A round in Oct 2026. Based in Copenhagen, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Copenhagen, Denmarkbreyetx.com ↗
Total raised
€72M
€71,500,000
Funding rounds
2
Investors
9
distinct backers
Active since
2022-11
latest 2026-10
Funding by year
EUR raised per year · 2026 YTDBreye Therapeutics — funding by year — interactive chart.
Data table
| Breye Therapeutics — funding by year | |
|---|---|
| 2022 | €4.0M |
| 2026 | €68M |
Signals
High confidenceRaise-next likelihood18
base rate 44% for Series A
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood19
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-02 | Series A | €68M | Catalyze Capital,EIFO,Innovestor Life Science Fund,Ljungström family office,Mission BioCapital,Modi Ventures+3 more | View deal → |
| 2022-11-11 | Seed | €4.0M | Novo Holdings,Sound Bioventures | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData